TITLE

UBS Pharma Forum Yields M&A Sound Bites

AUTHOR(S)
Cohen, Judy Radler
PUB. DATE
May 2006
SOURCE
Mergers & Acquisitions Report;5/1/2006, Vol. 19 Issue 17, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on speculations regarding the possible spinoff of Rosemont Pharmaceuticals by Savient Pharmaceuticals Inc. Market capitalization review of Rosemont conducted by Savient according to remarks by CEO Christopher Clement at the 2006 UBS Global Specialty Pharmaceuticals Conference in New York; Decision of Savient to hire Citigroup rather than former advisor UBS for the Rosemont mandate.
ACCESSION #
20794839

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics